Recommendations of the 5th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD5)
This module provides an overview of the evidence-based recommendations on the diagnosis and treatment of Alzheimer’s disease (AD) and related dementia from the five Canadian Consensus Conferences on the Diagnosis and Treatment of Dementia. Topics included: (1) utility of the National Institute of Aging (NIA) research framework for clinical AD diagnosis; (2) updating diagnostic criteria for vascular cognitive impairment and its management; (3) dementia case finding and detection; (4) use of neuroimaging and fluid biomarkers in diagnosis; (5) use of non-cognitive markers of dementia for better dementia detection; (6) risk reduction/prevention; (7) psychosocial and non-pharmacological interventions; and (8) deprescription of medications used to treat dementia.
The content provided is only for your own individual educational and non-commercial use. Any additional use, including use with other individuals or for any commercial use, is strictly prohibited without obtaining express permission from the copyright owner.
Publications
Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
CCCDTD5: research diagnostic criteria for Alzheimer's Disease
Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment
CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scales
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus
CCCDTD5: Reducing the risk of later‐life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD‐5)
CCCDTD5: Individual and community‐based psychosocial and other non‐pharmacological interventions to support persons living with dementia and their caregivers
Early stages Alzheimer’s disease: Evolving the care team for optimal patient management
Facilitating detection and management of Mild Cognitive Impairment due to Alzheimer’s disease and mild Alzheimer’s disease dementia
Useful Sites
Alzheimer Society Canada
